Physician

Carlos R Galvao-Sobrinho, MD, PHD

According to 2025 Medicare claims, Carlos Galvao-Sobrinho, MD, PHD (NPI: 1073936274) practices nephrology in the Racine-Mount Pleasant, WI market, with the plurality of this provider's patient population coming from Racine, WI. This provider's primary affiliated billing organization is ASCENSION MEDICAL GROUP-SOUTHEAST WISCONSIN INC (NPI: 1609881077; TIN: 391791586) and primary practice location at 53403-1176. Galvao-Sobrinho is affiliated with the Ascension Care Management Health Partners Wisconsin, LLC (ACO ID: A5329), participating under the MSSP model.

Galvao-Sobrinho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 232 traditional Medicare patients, billed 729 HCPCS/CPT codes, and received $90,465 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,608 prescription claims across 334 beneficiaries totaling $155,756 in drug costs, led by Lokelma (Sodium Zirconium Cyclosilicate). 2018 DME data shows 24 claims. Open Payments data shows 4 records totaling $95. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,468 and ending at $155,756. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	51	88	$5,908
2017	144	361	$23,127
2018	170	992	$42,609
2019	352	1,482	$149,176
2020	323	1,379	$143,926
2021	306	1,135	$142,938
2022	259	833	$111,062
2023	241	828	$118,905
2024	232	729	$90,465

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	13	$2,468
2016	72	303	$14,641
2017	212	2,936	$134,770
2018	361	5,460	$321,255
2019	358	2,837	$209,378
2020	260	1,805	$159,433
2021	293	2,138	$210,592
2022	304	2,322	$183,031
2023	313	2,503	$188,035
2024	334	2,608	$155,756

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$513
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	45	121	$262
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	33	49	$217
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	33	81	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	85	154	$68
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	47	132	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lokelma	Sodium Zirconium Cyclosilicate	91	3,290	$39,506
Sevelamer Carbonate	Sevelamer Carbonate	141	5,121	$20,109
Veltassa	Patiromer Calcium Sorbitex	34	963	$10,322
Clonidine	Clonidine	52	1,910	$6,705
Calcium Acetate	Calcium Acetate	80	4,110	$6,190

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$95	Ardelyx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carlos R. Galvao-Sobrinho, MD, PHD?

Tedicare shows public-source Medicare data for Carlos R. Galvao-Sobrinho, MD, PHD (NPI 1073936274), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos R. Galvao-Sobrinho, MD, PHD have ACO affiliation data?

Carlos R. Galvao-Sobrinho, MD, PHD is shown with ACO affiliation data for Ascension Care Management Health Partners Wisconsin, LLC (MSSP, ACO ID A5329).

What billing organization is linked to Carlos R. Galvao-Sobrinho, MD, PHD?

Carlos R. Galvao-Sobrinho, MD, PHD is linked to ASCENSION MEDICAL GROUP-SOUTHEAST WISCONSIN INC (billing NPI 1609881077) in the available physician profile data.

Does Carlos R. Galvao-Sobrinho, MD, PHD have Open Payments data?

Carlos R. Galvao-Sobrinho, MD, PHD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.